Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MQ-710 by IMVAQ Therapeutics for Cutaneous Squamous Cell Carcinoma (cSCC): Likelihood of Approval
MQ-710 is under clinical development by IMVAQ Therapeutics and currently in Phase I for Cutaneous Squamous Cell Carcinoma (cSCC). According...